Yoffe Investment Management LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Yoffe Investment Management LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 2,435 shares of the healthcare conglomerate's stock, valued at approximately $1,232,000. UnitedHealth Group makes up 1.3% of Yoffe Investment Management LLC's portfolio, making the stock its 16th biggest holding.

A number of other large investors also recently made changes to their positions in the company. Howard Capital Management Group LLC bought a new position in UnitedHealth Group during the third quarter valued at about $341,000. Principal Financial Group Inc. grew its position in shares of UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after acquiring an additional 180,479 shares during the period. Jacobs Levy Equity Management Inc. purchased a new position in UnitedHealth Group in the third quarter valued at approximately $319,000. Reynders McVeigh Capital Management LLC increased its position in UnitedHealth Group by 6.8% in the third quarter. Reynders McVeigh Capital Management LLC now owns 812 shares of the healthcare conglomerate's stock worth $475,000 after buying an additional 52 shares during the last quarter. Finally, Rench Wealth Management Inc. lifted its position in shares of UnitedHealth Group by 6.0% during the 3rd quarter. Rench Wealth Management Inc. now owns 11,395 shares of the healthcare conglomerate's stock valued at $6,662,000 after buying an additional 645 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Remove Ads

UnitedHealth Group Trading Down 2.9 %

Shares of UnitedHealth Group stock traded down $15.50 during midday trading on Friday, reaching $524.94. 9,914,705 shares of the company's stock traded hands, compared to its average volume of 4,261,985. The stock has a 50 day moving average of $509.24 and a 200-day moving average of $542.37. The company has a market cap of $480.17 billion, a PE ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $5.83 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.33% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have commented on UNH shares. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Wells Fargo & Company cut their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Finally, Barclays reduced their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.